Cosmos Health (COSM) Issues Guidance

Go back to Cosmos Health (COSM) Issues Guidance

Cosmos Health Introduces Guidance; Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026; Recaps Significant Events Reported So Far in 2023

September 12, 2023 8:33 AM EDT

Company reaches major strategic inflection point, with operations and revenue ramp-up underwayInaugural 2026 guidance introduced; target to achieve:More than $180 million in gross annual revenueEBITDA in excess of $20 millionSo far in 2023, among other achievements:Completed three acquisitionsMade notable progress in R&DNutraceutical brands "Sky Premium Life" and "Mediterranation" experiencing significant market success, expanding into new sales channels and geographiesMaintains a robust balance sheet with negligible debt and a strong, diversified asset baseActively exploring initiatives to enhance shareholder... More